Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mutation Correlates with a Higher Prostate Cancer Mortality Risk.

2.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

3.

Radiation therapy can promote amphiregulin, which increases growth of metastases

4.

Despite Medicare Coverage, Cancer Genomic Testing Still Low

5.

Q&A: Nipple-Sparing Mastectomy After Breast Radiation


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot